INO, RNN, AMPE-Late Afternoon Biopharmaceutical Picks-source: SimonSaysStocks.com

INO, RNN, AMPE-Late Afternoon Biopharmaceutical Picks. SimonSaysStocks.com provides you with the most up-to-date penny stock alerts, Join now for more free penny stock alerts.
By: Editorial Staff
 
June 22, 2010 - PRLog -- SimonSaysStocks is pleased to bring investors special situation stocks which have a high potential for price appreciation.  These companies have interesting business models and they have to execute on the business development level to bring value to shareholders.  Some of our past picks had soared over 200%.  To view some of our profiled stocks, please visit our website at www.simonsaysstocks.com

Inovio Pharmaceuticals Inc , focusing on cancer and infectious diseases, is a company involved in the exploration and development of their DNA delivery technology. INO, last at $1.12 a share, uses their technology to amplify the body’s ability to take biopharmaceuticals. Trading between $1.10 and $1.16, INO experienced an increase of 5.7% and a gain of +0.06 early this afternoon.

Rexahn Pharmaceuticals Inc , a clinical stage company, was last at $1.78 a share. RNN focuses on finding cures for cancer and central nervous system related disorders. Rexahn, last trading between $1.45 and $1.91, released news stating that their products Zoraxel and Serdaxin are close to deals with pharmaceutical companies. RNN was last at an increase of 23.9% and a gain of +0.34.  

Ampio Pharmaceuticals Inc  is a Delaware corporation engaged in the development of drugs to cure diseases like Metabolic disease and kidney disease. AMPE, up 17.5% and at a gain of +0.35, has two products being developed (Optina and Vasaloc) for diabetic related diseases. Ampio was last trading at $2.35 a share in the early afternoon.  


About SimonSaysStocks.com

SimonSaysStocks.com is an independent electronic publication that provides information on selected publicly traded companies. SimonSaysStocks.com is not a registered investment advisor or broker-dealer. SimonSaysStocks.com’s affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please follow us on twitter and facebook for further updates. We recommend you to do your own Due Diligence before investing in any of the stocks mentioned above.
End
Source:Editorial Staff
Email:***@simonsaysstocks.com Email Verified
Tags:Ino, Rnn, Ampe, Gain, Growth, Simon Says Stocks, Penny Stock, Biopharmaceutical, Pharmacy, Drugs, Disease, Cure
Industry:Business, Financial, Biotech
Location:Cheyenne - Wyoming - United States
Account Email Address Verified     Disclaimer     Report Abuse
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share